Comparison of targeted next generation sequencing assays in non-small cell lung cancer patients

Abstract Non-small cell lung cancer (NSCLC) is the most prevalent type of lung cancer the mutational spectrum of which has been extensively characterized. Treatment of patients with NSCLC based on their molecular profile is now part of the standard clinical care. The aim of this study was firstly to...

Cijeli opis

Bibliografski detalji

Glavni autori:	Ieva Drejeriene, Jurate Gruode, Saulius Cicenas, Charalambos Loizides, Alexia Eliades, Achilleas Achilleos, Elena Kypri, Kyriakos Tsangaras, Marios Ioannides, George Koumbaris, Diana Stanciute, Arnoldas Krasauskas, Philippos C. Patsalis
Format:	Artigo
Jezik:	Inglês
Izdano:	Springer 2024-12-01
Serija:	Discover Oncology
Teme:	NSCLC mutational profile clinical utility next generation sequencing
Online pristup:	https://doi.org/10.1007/s12672-024-01640-7
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!